Concepedia

Ulrike Teichmann

UT

17

Publications

1.3K

Citations

15

H-Index

1996

Active since

Affiliations

Max Planck Institute for Biophysical Chemistry(Current)

University of Göttingen

German Center for Neurodegenerative Diseases

Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103

Universitätsmedizin Göttingen

Ulrike Teichmann is an author at Max Planck Institute for Biophysical Chemistry specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

1996–2021

17

Publications

17

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease

Jens A. Wagner, Sergey Ryazanov, Andrei Leonov et al. · Acta Neuropathologica · 2013 · 439 citations · Full text

cDNA microarrays detect activation of a myogenic transcription program by the<i>PAX3-FKHR</i>fusion oncogene

Javed Khan, Michael Bittner, Lao H. Saal et al. · Proceedings of the National Academy of Sciences · 1999 · 317 citations

, , +16

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

Thomas Güttler, Metin Aksu, Antje Dickmanns et al. · The EMBO Journal · 2021 · 104 citations · Full text

Substitution of PIM1 Protease in Mitochondria by Escherichia coli Lon Protease

Ulrike Teichmann, Luc van Dyck, Bernard Guiard et al. · Journal of Biological Chemistry · 1996 · 62 citations · Full text

, , +15

Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

Sonja Offner, Armin Hekele, Ulrike Teichmann et al. · Cancer Immunology Immunotherapy · 2004 · 61 citations · Full text

, , +6

Rows per page

1–5 of 17